exenatide once weekly
H8O-MC-GWCH (DURATION - 4)
Phase 3 small_molecule completed
Quick answer
exenatide once weekly for Type 2 Diabetes Mellitus is a Phase 3 program (small_molecule) at AstraZeneca with 2 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed